Regulatory Watch: High Intensity Functional Training Trial for Elderly Sarcopenia Enters Not Yet Recruiting Phase

By Dr. Hatem Rabeh · Published February 10, 2026 · Updated March 16, 2026

As of February 11, 2026, a Cairo University led study examines a high intensity functional training program for older adults with sarcopenia. The ClinicalTrials.gov record NCT07399301 lists high intensity functional training and a Sham comparator and states the focus includes physical performance and mental health outcomes. The trial is not yet recruiting, signaling early development in an area where future device oriented therapies may be explored. This report summarizes what is publicly available and what regulators may watch as the program progresses.

In this article we break down what the record shows, why it matters to professionals in regulation and quality, and what stakeholders should monitor as the study moves forward.

What is the trial about?

The record concerns a study in a population with geriatric sarcopenia. It lists High Intensity Functional Training as the active intervention and a Sham as the comparator. The exact primary and secondary endpoints are not provided in the excerpt, but the title implies interests in physical performance and mental health domains. The sponsor is Cairo University, and the entry is described as Not yet Recruiting as of the published time stamp.

From a regulatory perspective, the description points to a training based approach rather than a device being evaluated directly. Should future iterations integrate devices or software to guide training, the applicable regulatory pathway would hinge on the intended use and risk class of the device under MDR Annex XIV and related guidance.

What are the interventions and control?

The intervention is described as High Intensity Functional Training. This typically involves time intense, effortful physical tasks designed to improve strength, balance and mobility. The control is listed as Sham, implying a non active comparator used to blind participants to the allocation in some trial designs. The record does not specify duration, frequency, supervision level or outcome measures in this excerpt.

Who sponsors and what is the status?

The study sponsor is Cairo University. The status is Not yet Recruiting, indicating the trial has not started enrolling participants at the time of the record. The absence of enrollment detail means regulatory authorities will monitor updates for any changes in recruitment status, amendments to the protocol or safety reporting requirements.

What are the regulatory implications for future device oriented interventions?

While the current record describes a training based intervention, regulators consider any future device oriented adaptation with attention to intended use, risk class and claimed performance. If a device is implicated in driving or enhancing a functional training program, sponsors would need to align with MDR requirements including clear intended purpose, performance claims and safety data. This article underscores the importance of transparent disclosure of intervention details and endpoints to permit regulators to assess risk, benefit and device classification pathways.

How is the study structured and endpoints?

The available excerpt names high intensity functional training and a sham comparator, with the implied focus on physical performance and mental health outcomes. Specific design features such as randomization method, blinding, sample size, duration and measured endpoints are not stated in the source. Regulators will expect comprehensive protocol details if the study progresses to reporting results that could influence device or therapy approvals or recommendations for clinical practice.